ArticleFrontiers in veterinary science2026
Signalment, clinical characteristics, and echocardiographic findings in dogs affected by secondary atrial fibrillation with and without concomitant frequent and complex ventricular arrhythmias.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Assessment of dogs with atrial fibrillation (AF) and ventricular arrhythmias (VAs), two arrhythmias that can coexist, is traditionally based on 24-h Holter monitoring. However, this test may not always be feasible. The aim of this study was to determine whether alternative methods exist to distinguish dogs affected by secondary AF with frequent and complex VAs from those without. Methods: In this multicenter retrospective study, electronic databases from five centers were searched for dogs with a diagnosis of secondary AF. For inclusion, complete clinical, echocardiographic and 24-h Holter data had to be available for each dog. Signalment, clinical, and echocardiographic variables of left cardiac dimension and function were compared between dogs with secondary AF exhibiting frequent ventricular premature complexes (VPCs; ≥100/Holter) or severe VAs (Lown-Wolf grade ≥4) and those without. Results: Fifty-nine dogs, including 35/59 (59.3%) dogs with myxomatous mitral valve disease, 17/59 (28.8%) dogs with dilated cardiomyopathy, and 7/59 (11.9%) dogs with congenital heart disease, were evaluated. Compensated and decompensated cardiac disease was diagnosed in 10/59 (16.9%) and 49/59 (83.1%) dogs, respectively. Holter monitoring detected VAs associated with AF in 58/59 (98.3%) dogs. Among dogs with VPCs, the median number of VPCs was 265 (1-1,759) and 32/59 (54.2%) dogs had ≥100 VPCs/Holter. Regarding VA complexity, 34/59 (57.6%) dogs exhibited a Lown-Wolf grade ≥4. Statistical analyses revealed that none of the 17 analyzed variables reached significance in differentiating dogs with and without frequent VPCs, as well as dogs with and without complex VAs. Discussion: In dogs with secondary AF, VAs are usually present and are frequently of clinical relevance according to their Lown-Wolf grade. However, signalment, clinical presentation, and conventional echocardiographic data do not reliably distinguish dogs with frequent VPCs or complex VAs from those without, reinforcing the indispensable role of 24-h Holter monitoring for the accurate assessment of these subjects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.